Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Webster

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
American Scientist|September 28, 2011
Mitochondrial Death ChannelsKeith A Webster
Trends in Pharmacological Sciences|August 19, 2007
Programmed death as a therapeutic target to reduce myocardial infarctionKeith A Webster
Nature Medicine|November 9, 2012
A sirtuin link between metabolism and heart diseaseKeith A Webster
Trends in Cardiovascular Medicine|November 16, 2004
Genomic and proteomic profiles of heart diseaseHoward Prentice, Keith A Webster
Circulation Research|June 29, 2002
Preventing apoptosis with thioredoxin: ASK me howNanette H Bishopric, Keith A Webster
Circulation|December 17, 2003
Apoptosis inhibitors for heart diseaseKeith A Webster, Nanette H Bishopric
Oncotarget|May 10, 2014
Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasisRegina M Graham, John W Thompson, Keith A Webster
Life Sciences|October 17, 2015
BNIP3 promotes calcium and calpain-dependent cell deathRegina M Graham, John W Thompson, Keith A Webster
IUBMB Life|November 21, 2002
Gene and cell therapy for heart diseaseRegina M Graham, Nanette H Bishopric, Keith A Webster
Drug Discovery Today|November 7, 2022
Profiling disease-selective drug targets: From proteomics to ligandomicsPrabuddha Waduge, Hong Tian, Keith A Webster, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
American Scientist|September 28, 2011
Mitochondrial Death ChannelsKeith A Webster
Trends in Pharmacological Sciences|August 19, 2007
Programmed death as a therapeutic target to reduce myocardial infarctionKeith A Webster
Nature Medicine|November 9, 2012
A sirtuin link between metabolism and heart diseaseKeith A Webster
Trends in Cardiovascular Medicine|November 16, 2004
Genomic and proteomic profiles of heart diseaseHoward Prentice, Keith A Webster
Circulation Research|June 29, 2002
Preventing apoptosis with thioredoxin: ASK me howNanette H Bishopric, Keith A Webster
Circulation|December 17, 2003
Apoptosis inhibitors for heart diseaseKeith A Webster, Nanette H Bishopric
Oncotarget|May 10, 2014
Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasisRegina M Graham, John W Thompson, Keith A Webster
Life Sciences|October 17, 2015
BNIP3 promotes calcium and calpain-dependent cell deathRegina M Graham, John W Thompson, Keith A Webster
IUBMB Life|November 21, 2002
Gene and cell therapy for heart diseaseRegina M Graham, Nanette H Bishopric, Keith A Webster
Drug Discovery Today|November 7, 2022
Profiling disease-selective drug targets: From proteomics to ligandomicsPrabuddha Waduge, Hong Tian, Keith A Webster, et al.
Pageof 11